News
On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in ...
The U.S. Centers for Disease Control and Prevention’s outside panel of vaccine experts on Tuesday discussed narrowing ...
The CDC's expert panel explores narrowing COVID-19 booster shot guidelines to focus on high-risk groups. Despite concerns ...
Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...
Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...
Amid the ongoing measles outbreak, many people might be wondering: do I need to get a measles vaccine booster?
The CDC's vaccine committee will convene for a two-day meeting this week to consider recommendations on vaccines, including ...
Paul Vieira covers Canada for The Wall Street Journal, and is based in Ottawa.
This cohort study adds to a growing body of evidence that COVID-19 vaccines save lives not just by preventing infection, but ...
The committee endorsed lowering the age at which some people can receive RSV vaccines, but stopped short of recommending ...
US CDC advisers discuss narrowing use of COVID-19 booster shots The U.S. Centers ... 2025 Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents Pfizer and BioNTech ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback